10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 153,644 | 146,819 | 134,285 | 156,232 | 131,072 |
| Cost of Goods | 58,115 | 47,207 | 35,895 | 36,827 | 30,377 |
| Gross Profit | 95,529 | 99,612 | 98,390 | 119,405 | 100,695 |
| Operating Expenses | 190,439 | 163,177 | 151,273 | 143,328 | 141,068 |
| Operating Income | -94,795 | -63,358 | -51,988 | -23,096 | -39,996 |
| Interest Expense | 1 | 5 | 19 | 125 | 114 |
| Other Income | 3,052 | 2,596 | 2,353 | 6,810 | 75 |
| Pre-tax Income | -91,744 | -60,767 | -49,654 | -16,411 | -40,035 |
| Income Tax | 1,242 | 1,647 | 1,093 | 804 | 1,879 |
| Net Income Continuous | -92,986 | -62,414 | -50,747 | -17,215 | -41,914 |
| Net Income | $-92,986 | $-62,414 | $-50,747 | $-17,215 | $-41,914 |
| EPS Basic Total Ops | -0.79 | -0.53 | -0.44 | -0.14 | -0.37 |
| EPS Basic Continuous Ops | -0.79 | -0.53 | -0.44 | -0.15 | -0.37 |
| EPS Diluted Total Ops | -0.79 | -0.53 | -0.44 | -0.14 | -0.37 |
| EPS Diluted Continuous Ops | -0.79 | -0.53 | -0.44 | -0.15 | -0.37 |
| EBITDA(a) | $-83,375 | $-51,481 | $-43,372 | $-14,624 | $-31,881 |